Australis Capital Inc.

Equities

AUSA

CA05259R1073

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:54:46 2022-10-18 pm EDT 5-day change 1st Jan Change
0.025 CAD +25.00% Intraday chart for Australis Capital Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Australis Capital Inc. Appoints Robert Wilson as Its New CFO CI
Australis Capital Inc. Announces Executive Changes CI
Australis Capital Inc Completes Final New Jersey License Application Step CI
Australis Capital Inc. Announces Board Changes CI
Australis Capital Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Australis Capital Inc. Enters into Credit Facility with Lola Ventures CI
Australis Capital Inc. Completes Submission to the City of Millville, New Jersey CI
Australis Capital Inc. Appoints Jill Swainson as Member of Board of Directors CI
Australis Capital Inc. Enters into an Agreement with Hempire Farms, LLC CI
Australis Capital Inc. Announces Mr. Natural, an AUDACIOUS Brand, Launched Its First Product in Nevada: Full Spectrum Hash RSO CI
Australis Capital Inc. Collaborates with the Black Institute Group CI
Australis Capital Inc. Receives Provisional Cultivation License, as Well as A Provisional Manufacturing License in the State of New Jersey CI
AUDACIOUS and Golden Triangle Health Partner to Open the First Herbidus Medical Center in Bangkok CI
Transcript : Australis Capital Inc., Q3 2022 Earnings Call, Mar 02, 2022
Australis Capital Inc. entered into an agreement to acquire a 51% stake in Belle Fleur Manufacturing Facility in Massachusetts. CI
Australis Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Australis Capital Inc. completed the acquisition of Gary Maverick Inc. for $0.5 million. CI
Audacious Enters into Definitive Agreement with Golden Triangle Health CI
Transcript : Australis Capital Inc. - Shareholder/Analyst Call
AUDACIOUS to Enter New York Cannabis Market Through Partnership with First Americans, LLC CI
Australis Capital Inc. announced that it expects to receive CAD 20 million in funding from LDA Capital Limited CI
Australis Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Transcript : Australis Capital Inc., Q2 2022 Earnings Call, Nov 23, 2021
Playtertainment, Inc. announced that it has received $5 million in funding from Australis Capital Inc., Sharp Alpha Advisors, LLC, and other investors CI
AUDACIOUS Signs Term Sheet with Golden Triangle Health to Drive Entry into the Asia-Pacific Cannabis Market CI
Chart Australis Capital Inc.
More charts
Australis Capital Inc. is a multi-state operator in the cannabis industry in the United States. The Company is involved in the cannabis and horticultural industries in the United States and abroad. It is focused on brands and cannabis licenses in states with favorable economics. The Company also operates an engineering consulting firm. The Company advises on greenhouse design, build and operations throughout the world in cannabis and horticulture. Its operations range from providing sustainable cultivation design and optimization to retail storefronts, growing flowers in-house, and manufacturing brand, AUDACIOUS has products and solutions for everyone.
More about the company
  1. Stock Market
  2. Equities
  3. AUSA Stock
  4. News Australis Capital Inc.
  5. Australis Capital : Down 6% After Selling 9.9 Million Common Shares in the Capital of Body and Mind Inc.